Y-Mabs Therapeutics Inc (YMAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -81,028 | -43,274 | -19,161 | -17,057 | N/A |
| Depreciation Amortization | 166 | 29 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 2,617 | 1,261 | 2,385 | 836 | N/A |
| Other Working Capital | 2,665 | -47 | 2,745 | 3,353 | N/A |
| Other Operating Activity | 2,083 | 802 | -1,839 | 1,702 | 0 |
| Operating Cash Flow | $-73,497 | $-41,229 | $-15,870 | $-11,166 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,965 | -234 | N/A | N/A | N/A |
| Investing Cash Flow | $-1,965 | $-234 | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 134,704 | 99,765 | 89,844 | 19,338 | N/A |
| Common Stock Repurchased | N/A | N/A | N/A | -366 | N/A |
| Other Financing Activity | 0 | -1,002 | -258 | 0 | 0 |
| Financing Cash Flow | $134,704 | $98,763 | $89,586 | $18,972 | $N/A |
| Exchange Rate Effect | 23 | 56 | -104 | N/A | N/A |
| Beginning Cash Position | 147,871 | 90,515 | 16,903 | 9,069 | N/A |
| End Cash Position | 207,136 | 147,871 | 90,515 | 16,875 | N/A |
| Net Cash Flow | $59,265 | $57,356 | $73,612 | $7,806 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -73,497 | -41,229 | -15,870 | -11,166 | N/A |
| Capital Expenditure | -1,965 | -234 | N/A | N/A | N/A |
| Free Cash Flow | -75,462 | -41,463 | -15,870 | -11,166 | 0 |